Ontario Teachers Pension Plan Board trimmed its position in Chemed Co. (NYSE:CHE - Free Report) by 75.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,087 shares of the company's stock after selling 3,336 shares during the quarter. Ontario Teachers Pension Plan Board's holdings in Chemed were worth $653,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. SG Americas Securities LLC grew its holdings in shares of Chemed by 422.9% during the 2nd quarter. SG Americas Securities LLC now owns 7,551 shares of the company's stock worth $4,097,000 after purchasing an additional 6,107 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of Chemed by 292.7% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company's stock worth $673,000 after purchasing an additional 925 shares in the last quarter. Hsbc Holdings PLC grew its holdings in shares of Chemed by 110.0% during the 2nd quarter. Hsbc Holdings PLC now owns 10,638 shares of the company's stock worth $5,801,000 after purchasing an additional 5,572 shares in the last quarter. Evergreen Capital Management LLC acquired a new stake in shares of Chemed during the 2nd quarter worth $7,812,000. Finally, Quest Partners LLC grew its holdings in shares of Chemed by 634.3% during the 2nd quarter. Quest Partners LLC now owns 1,990 shares of the company's stock worth $1,080,000 after purchasing an additional 1,719 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Chemed
In other news, EVP Nicholas Michael Westfall sold 1,713 shares of the firm's stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the completion of the transaction, the executive vice president now directly owns 6,109 shares in the company, valued at $3,478,159.15. This trade represents a 21.90 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the transaction, the chief executive officer now owns 103,735 shares of the company's stock, valued at $62,117,555.35. This trade represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,113 shares of company stock worth $2,411,905. 3.32% of the stock is currently owned by insiders.
Chemed Price Performance
NYSE:CHE traded up $7.68 during trading hours on Friday, hitting $570.96. The company's stock had a trading volume of 113,335 shares, compared to its average volume of 86,127. The stock has a fifty day simple moving average of $579.16 and a 200-day simple moving average of $565.16. The company has a market capitalization of $8.59 billion, a P/E ratio of 28.64, a PEG ratio of 2.24 and a beta of 0.46. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62.
Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The business had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $5.32 earnings per share. On average, equities analysts predict that Chemed Co. will post 22.26 EPS for the current fiscal year.
Chemed Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed's dividend payout ratio (DPR) is presently 10.11%.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada reduced their target price on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th.
Read Our Latest Analysis on Chemed
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.